Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more
Alpha Cognition Inc (ACOG) - Total Liabilities
Latest total liabilities as of September 2025: $12.39 Million USD
Based on the latest financial reports, Alpha Cognition Inc (ACOG) has total liabilities worth $12.39 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Alpha Cognition Inc - Total Liabilities Trend (2020–2024)
This chart illustrates how Alpha Cognition Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Alpha Cognition Inc Competitors by Total Liabilities
The table below lists competitors of Alpha Cognition Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nexen Corporation
KO:005720
|
Korea | ₩3.26 Trillion |
|
NanoenTekInc
KQ:039860
|
Korea | ₩5.42 Billion |
|
Dusit Thani Public Company Limited
BK:DUSIT
|
Thailand | ฿30.70 Billion |
|
Kenilworth Systems C
PINK:KENS
|
USA | $7.44 Million |
|
Cardiol Therapeutics Inc Class A
NASDAQ:CRDL
|
USA | $3.39 Million |
|
Currenc Group Inc. Ordinary Shares
NASDAQ:CURR
|
USA | $62.18 Million |
|
Sutro Biopharma
NASDAQ:STRO
|
USA | $296.93 Million |
|
Mercer International Inc
NASDAQ:MERC
|
USA | $1.97 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Alpha Cognition Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpha Cognition Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpha Cognition Inc (2020–2024)
The table below shows the annual total liabilities of Alpha Cognition Inc from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.27 Million | +29.44% |
| 2023-12-31 | $7.16 Million | +67.75% |
| 2022-12-31 | $4.27 Million | +10.92% |
| 2021-12-31 | $3.85 Million | -54.27% |
| 2020-12-31 | $8.42 Million | -- |